Plasmodium

Plasmodium is a genus of unicellular eukaryotic parasites responsible for causing malaria, a life-threatening disease affecting millions globally. There are over 200 known species, with five primarily infecting humans: P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi, with P. falciparum being the most virulent and deadly. The parasite has a complex life cycle involving both a mosquito vector (Anopheles) and a vertebrate host (humans). In humans, Plasmodium infects liver cells before invading and multiplying within red blood cells, leading to the characteristic symptoms of malaria. Therapeutic strategies target various stages of the parasite's life cycle and its essential biological processes, such as hemoglobin digestion, mitochondrial function, and DNA synthesis. However, the development of drug resistance by Plasmodium species, particularly P. falciparum, poses a significant challenge to malaria control and eradication efforts.

Other names

Malaria parasite

Drugs targeting Plasmodium parasites employ various mechanisms. Many antimalarials, such as chloroquine and quinine, interfere with the parasite's digestion of hemoglobin in the blood stages, leading to the accumulation of toxic heme within the parasite's food vacuole. Artemisinin derivatives are activated by iron, targeting multiple parasite proteins and causing oxidative stress. Other drugs, like atovaquone, inhibit parasite mitochondrial electron transport, while proguanil inhibits dihydrofolate reductase, disrupting deoxythymidylate synthesis. Some antimalarials, such as quinine, intercalate into DNA, thereby disrupting the parasite's replication and transcription. Emerging strategies also involve targeting specific parasite proteins like protein kinases, which are vital for Plasmodium's life cycle, or epigenetic regulatory processes like DNA methylation.